𝔖 Bobbio Scriptorium
✦   LIBER   ✦

6.16. Genetic markers in patients with Hodgkin's disease

✍ Scribed by U. Sliwinski; P. Kühnl; P.S. Mitrou; W. Spielmann


Book ID
113368989
Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
172 KB
Volume
18
Category
Article
ISSN
0379-0738

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Intracranial Hodgkin's disease in two pa
✍ Ashigbi, Michael Y.; Venkatraj, Usha; Agarwal, Veneeta; Bello, Jackie; Wiernik, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

Intracranial Hodgkin's disease is very rare and is often a terminal event. The case of a 33-year-old man who relapsed in the anterior pituitary gland without other evidence of disease 6 months after extended field radiation therapy for Stage IIA Hodgkin's disease is presented. He remains well with n

Increased levels of circulating interleu
✍ Angela Gause; Rotraud Scholz; Sigrid Klein; Wolfram Jung; Volker Diehl; Hans Tes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Expression of interleukin‐6 (IL‐6) and IL‐6 receptors has been demonstrated in Hodgkin and Reed‐Sternberg (H and RS) cells __in vitro__ and __in vivo__. In order to evaluate the clinical significance of IL‐6 serum levels in patients with Hodgkin's disease (HD), we tested the sera of 56

Monocyte activation in patients with Hod
✍ Maria Kávai; Ernö Berßnyi; Attila Zsindely; Gyula Szegedi; Läszlö Fésüs 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB

Transglutaminase activity in monocytes and serum lysozyme level were tested in 40 patients with Hodgkin's disease and were found to be significantly increased. Transglutaminase activity in monocytes from patients in a clinicaly active stage of the disease was higher than in clinically inactive cases